Intercellular adhesion molecule-1 rs5498 in North India: Genetic spark for diabetic retinopathy inflammasome, not yet a clinical beacon
World Journal of Diabetes · 15.08.2026 · 17 (8)
DOI: 10.4239/wjd.116870 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Diabetes, online erschienen am 15.08.2026. Verfasst von Yi Luo und 2 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
In a case-control study involving 614 individuals with type 2 diabetes from northern India published in the World Journal of Diabetes , Kaur et al first reported a 1.6-fold increase in the diabetic retinopathy (DR) among carriers of the intercellular adhesion molecule-1 rs5498 GG genotype, whereas rs1799969 demonstrated no significant association. However, the relatively low odds ratio of 1.6 (95% confidence interval: 1.01-2.53) and population-attributable risk of only approximately 11% limits the clinical utility of genotyping rs5498 as a stand-alone marker. Readers should guard against interpreting this modest effect as justification for immediate clinical adoption. A meta-analysis of nine studies (1844 DR cases, 1595 controls) revealed no overall or Asian-specific association with rs5498, although a modest effect was observed in the Caucasian subgroup. While this study addresses a key data gap in the North-Indian population, employs rigorous phenotyping with validated genotyping, and provides new insights into DR susceptibility, the cross-sectional design, absence of functional data, small effect size, and interethnic heterogeneity preclude immediate clinical translation. Future large-scale longitudinal cohort studies, gene-environment interaction analyses, and multi-omic integration are required to establish the causal relevance of intercellular adhesion molecule-1 variations and to define its potential as a therapeutic target for precise DR prevention.
Zitieren
APA
Luo, Y., Zhou, S., & Guo, R. (2026). Intercellular adhesion molecule-1 rs5498 in North India: Genetic spark for diabetic retinopathy inflammasome, not yet a clinical beacon. World Journal of Diabetes, 17(8). https://doi.org/10.4239/wjd.116870
Vancouver
Luo Y, Zhou S, Guo R. Intercellular adhesion molecule-1 rs5498 in North India: Genetic spark for diabetic retinopathy inflammasome, not yet a clinical beacon. World Journal of Diabetes. 2026;17(8). doi:10.4239/wjd.116870
BibTeX
@article{Luo2026,
author = {Luo, Yi and Zhou, Shun-Ping and Guo, Rong},
title = {Intercellular adhesion molecule-1 rs5498 in North India: Genetic spark for diabetic retinopathy inflammasome, not yet a clinical beacon},
journal = {World Journal of Diabetes},
year = {2026},
volume = {17},
number = {8},
doi = {10.4239/wjd.116870}
}
EUVIMED